Blood in your stool or very dark, tarry bowel movements
No significant heterogeneity was found among RCTs in the diabetic subgroup (I 2 = 0%, P = 0.38), and thus fix-effects model was chosen
Taken together, these effects help explain why GLP-1 drugs have produced more durable weight loss than many earlier pharmacologic approaches, which often relied on stimulant-based appetite suppression or had limited tolerability
Mar 18, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Therapies, Type 2 Diabetes, Type 2 Diabetes 961 views Type 2 diabetes often feels like a slow-burning fire that gradually damages the body over time
When these elements work together, the overall experience feels confident, human, and sustainable rather than rushed or opaque